ESMO Video Commentary – New promising options are available for kidney cancer

Speaker: Cora Sternberg

Two drugs are changing the current landscape for the treatment of advanced metastatic renal cell carcinoma, prolonging survival. These two drugs are likely to change the clinical practice, according to Cora Sternberg Chief of the Department of Medical Oncology at the San Camillo-Forlanini Hospital in Rome, Italy. Read more...

Discussion Points